338 related articles for article (PubMed ID: 26685159)
1. Reduced cholesterol levels impair Smoothened activation in Smith-Lemli-Opitz syndrome.
Blassberg R; Macrae JI; Briscoe J; Jacob J
Hum Mol Genet; 2016 Feb; 25(4):693-705. PubMed ID: 26685159
[TBL] [Abstract][Full Text] [Related]
2. Discordant phenotype and sterol biochemistry in Smith-Lemli-Opitz syndrome.
Koo G; Conley SK; Wassif CA; Porter FD
Am J Med Genet A; 2010 Aug; 152A(8):2094-8. PubMed ID: 20635399
[TBL] [Abstract][Full Text] [Related]
3. Modeling Smith-Lemli-Opitz syndrome with induced pluripotent stem cells reveals a causal role for Wnt/β-catenin defects in neuronal cholesterol synthesis phenotypes.
Francis KR; Ton AN; Xin Y; O'Halloran PE; Wassif CA; Malik N; Williams IM; Cluzeau CV; Trivedi NS; Pavan WJ; Cho W; Westphal H; Porter FD
Nat Med; 2016 Apr; 22(4):388-96. PubMed ID: 26998835
[TBL] [Abstract][Full Text] [Related]
4. Recent insights into the Smith-Lemli-Opitz syndrome.
Yu H; Patel SB
Clin Genet; 2005 Nov; 68(5):383-91. PubMed ID: 16207203
[TBL] [Abstract][Full Text] [Related]
5. Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts.
Wassif CA; Krakowiak PA; Wright BS; Gewandter JS; Sterner AL; Javitt N; Yergey AL; Porter FD
Mol Genet Metab; 2005 Jun; 85(2):96-107. PubMed ID: 15896653
[TBL] [Abstract][Full Text] [Related]
6. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome.
Fitzky BU; Moebius FF; Asaoka H; Waage-Baudet H; Xu L; Xu G; Maeda N; Kluckman K; Hiller S; Yu H; Batta AK; Shefer S; Chen T; Salen G; Sulik K; Simoni RD; Ness GC; Glossmann H; Patel SB; Tint GS
J Clin Invest; 2001 Sep; 108(6):905-15. PubMed ID: 11560960
[TBL] [Abstract][Full Text] [Related]
7. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
[TBL] [Abstract][Full Text] [Related]
8. Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome.
Ginat S; Battaile KP; Battaile BC; Maslen C; Gibson KM; Steiner RD
Mol Genet Metab; 2004; 83(1-2):175-83. PubMed ID: 15464432
[TBL] [Abstract][Full Text] [Related]
9. Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management.
Porter FD
Eur J Hum Genet; 2008 May; 16(5):535-41. PubMed ID: 18285838
[TBL] [Abstract][Full Text] [Related]
10. Mutational spectrum of Smith-Lemli-Opitz syndrome.
Waterham HR; Hennekam RC
Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):263-84. PubMed ID: 23042628
[TBL] [Abstract][Full Text] [Related]
11. Abnormal cholesterol biosynthesis as in Smith-Lemli-Opitz syndrome disrupts normal skeletal development in the rat.
Kolf-Clauw M; Chevy F; Ponsart C
J Lab Clin Med; 1998 Mar; 131(3):222-7. PubMed ID: 9523845
[TBL] [Abstract][Full Text] [Related]
12. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome.
Witsch-Baumgartner M; Fitzky BU; Ogorelkova M; Kraft HG; Moebius FF; Glossmann H; Seedorf U; Gillessen-Kaesbach G; Hoffmann GF; Clayton P; Kelley RI; Utermann G
Am J Hum Genet; 2000 Feb; 66(2):402-12. PubMed ID: 10677299
[TBL] [Abstract][Full Text] [Related]
13. Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology.
Nowaczyk MJ; Irons MB
Am J Med Genet C Semin Med Genet; 2012 Nov; 160C(4):250-62. PubMed ID: 23059950
[TBL] [Abstract][Full Text] [Related]
14. Smith-Lemli-Opitz syndrome.
DeBarber AE; Eroglu Y; Merkens LS; Pappu AS; Steiner RD
Expert Rev Mol Med; 2011 Jul; 13():e24. PubMed ID: 21777499
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz Syndrome.
Hall P; Michels V; Gavrilov D; Matern D; Oglesbee D; Raymond K; Rinaldo P; Tortorelli S
Mol Genet Metab; 2013; 110(1-2):176-8. PubMed ID: 23628460
[TBL] [Abstract][Full Text] [Related]
16. Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis.
Battaile KP; Steiner RD
Mol Genet Metab; 2000; 71(1-2):154-62. PubMed ID: 11001806
[TBL] [Abstract][Full Text] [Related]
17. Negative regulation of Hedgehog signaling by the cholesterogenic enzyme 7-dehydrocholesterol reductase.
Koide T; Hayata T; Cho KW
Development; 2006 Jun; 133(12):2395-405. PubMed ID: 16687448
[TBL] [Abstract][Full Text] [Related]
18. Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype.
Prasad C; Marles S; Prasad AN; Nikkel S; Longstaffe S; Peabody D; Eng B; Wright S; Waye JS; Nowaczyk MJ
Am J Med Genet; 2002 Feb; 108(1):64-8. PubMed ID: 11857552
[TBL] [Abstract][Full Text] [Related]
19. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A; Irons M; Elias ER
J Lipid Res; 1996 Jun; 37(6):1169-80. PubMed ID: 8808751
[TBL] [Abstract][Full Text] [Related]
20. Holoprosencephaly in RSH/Smith-Lemli-Opitz syndrome: does abnormal cholesterol metabolism affect the function of Sonic Hedgehog?
Kelley RL; Roessler E; Hennekam RC; Feldman GL; Kosaki K; Jones MC; Palumbos JC; Muenke M
Am J Med Genet; 1996 Dec; 66(4):478-84. PubMed ID: 8989473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
